Pasar al contenido principal
Inicio

Dedicated to discovery

  • Acerca de ELGA
    • Acerca de ELGA
    • Empleo
    • Eventos
  • Soporte
    • Planificación de laboratorio
  • Contacto
  • EN
  • DE
  • FR
  • IT
  • PT
  • EN-US
Inicio
  • Productos
    • PURELAB
      • PURELAB® Dispenser
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • Purelab Chorus 2+ (RO/DI/UV) / (RO/EDI/UV)
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 150
      • MEDICA® 7/15
      • MEDICA® BIOX 2024
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY® 30
    • Gama completa de productos ELGA
  • Aplicaciones
    • Análisis microbiológico
    • Bioquímica clínica
    • Cromatografía de gases
    • Cromatografía líquida
      • High Performance Liquid Chromatography
    • Cultivos celulares
    • Electroquímica
    • Espectrofotometría
    • Espectrometría de masas
    • Espectroscopia atómica
    • Genética
    • High Performance Liquid Chromatography (HPLC)
    • Inmunoquímica
    • Requisitos generales de agua de laboratorio
  • Tecnologías
    • Carbón activado
    • Electrodesionización (EDI)
    • Filtración
    • Intercambio iónico
    • PureSure
    • Ultravioleta
    • Ósmosis inversa
  • Impurezas en el agua
    • Compuestos inorgánicos
    • Compuestos orgánicos
    • Gases disueltos
    • Microorganismos y bacterias
    • Partículas
  • Conocimiento
    • BROSCHÜREN
    • Blog
    • Casos prácticos
    • Agua ultrapura
    • Manuales e informes técnicos
  • Where to buy
  • Contacto
Home
  • Contacto
  • Productos
    • PURELAB
      • PURELAB® Dispenser
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • Purelab Chorus 2+ (RO/DI/UV) / (RO/EDI/UV)
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 150
      • MEDICA® 7/15
      • MEDICA® BIOX 2024
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY® 30
    • Gama completa de productos ELGA
  • Aplicaciones
    • Análisis microbiológico
    • Bioquímica clínica
    • Cromatografía de gases
    • Cromatografía líquida
      • High Performance Liquid Chromatography
    • Cultivos celulares
    • Electroquímica
    • Espectrofotometría
    • Espectrometría de masas
    • Espectroscopia atómica
    • Genética
    • High Performance Liquid Chromatography (HPLC)
    • Inmunoquímica
    • Requisitos generales de agua de laboratorio
  • Tecnologías
    • Carbón activado
    • Electrodesionización (EDI)
    • Filtración
    • Intercambio iónico
    • PureSure
    • Ultravioleta
    • Ósmosis inversa
  • Impurezas en el agua
    • Compuestos inorgánicos
    • Compuestos orgánicos
    • Gases disueltos
    • Microorganismos y bacterias
    • Partículas
  • Conocimiento
    • BROSCHÜREN
    • Blog
    • Casos prácticos
    • Agua ultrapura
    • Manuales e informes técnicos
  • Where to buy
  • Contacto
  • Acerca de ELGA
    • Acerca de ELGA
    • Empleo
    • Eventos
  • Soporte
    • Planificación de laboratorio
  • Contacto
  • EN
  • DE
  • FR
  • IT
  • PT
  • EN-US
  • Política de privacidad
  • Términos y condiciones
  • Cumplimiento legal internacional
  • Patentes
  • Trademarks
  • Aviso legal
  • Lipid Nanoparticles for Dermal Drug Delivery
Analytical Chemistry
Clinical & Pharma

Lipid Nanoparticles for Dermal Drug Delivery

27 Dic 2021
- by Dr Alison Halliday

A cross section scientific view of eperdermis cells sub layer beneath skin on an isolated background - 3D render

Lipid nanoparticles are a holistically superior formulation for dermal drug products, which combine effective drug delivery and skin carrying properties at the same time.

Skin is a popular route for the delivery of locally and systemically acting drugs. Although the skin acts as a natural barrier against the penetration of foreign materials, opportunities exist for the delivery of therapeutic nanoparticles.

Lipid nanoparticles (LNPs) are an attractive option for dermal drug delivery. Encapsulating lipophilic active ingredients within LNPs increases the stability of chemically labile active ingredients – and after skin application, LNP formulations form a lipid film known as an ‘invisible patch’, increasing skin hydration and improving dermal penetration. 

Many scientific studies have already proven the superiority of LNPs over classical skin formulations such as emulsions or creams, or nanoemulsions. This drug delivery system is exploited in various cosmeceutical products – and has recently been described as the most successful carrier for skin delivery.

But until now, there has been no proof-of-concept study to investigate if LNPs are indeed a holistically superior formulation principle when compared to other dermal drug delivery strategies.

A Comprehensive Comparison

In a new study, published in Drug Delivery and Translational Research, researchers directly compared all the biopharmaceutical properties of LNPs against classical formulations.1

The team produced LNPs, a macroemulsion and a nanoemulsion formulation with similar chemical compositions and characterised their physiochemical properties. The macroemulsion was a semi–solid formulation with an average droplet size of 10–15 µm. The nanoemulsion (an oil–in–water emulsion) had a droplet size of around 150 nm, and the LNP formulation had a slightly larger particle size of around 165 nm.

The researchers then determined the biopharmaceutical properties of these formulations and compared to an oily solution. They found that the LNPs provided the best dermal penetration efficiency, chemical stability of the incorporated active ingredient, and the most pronounced skin hydration and skin carrying properties. The LNPs were the only formulation to form an invisible patch on the skin.

The team used ultrapure water generated from an ELGA PURELAB® laboratory water purification system as a dispersion medium to produce the formulations, mimimising the risk of introducing contaminants that may affect their results.

A Superior Formulation

This study confirms the advantages of LNPs – increased chemical stability for chemically labile active ingredients, improved and longer–lasting skin hydration due to the formation of an invisible patch, and improved dermal penetration of lipophilic active ingredients – over classical formulation principles.

The results demonstrate that chemical stability and film formation after dermal application are major prerequisites for effective skin penetration. The chemical stability of the active ingredient must be ensured not only in the packaging container but also during the entire penetration time after dermal application. Film formation increases skin hydration, which improves penetration efficiency.

Future studies are now needed to develop even better LNP formulations with tailor–made skin properties and penetration profiles.

Why Choose ELGA LabWater?

At ELGA LabWater, our expert engineers, chemists and scientists are at the forefront of technological innovation. They continue to introduce game-changing features to the lab water market. 

 

Reference:

  1. Wiemann, S. and Keck, C.M. Are lipid nanoparticles really superior? A holistic proof of concept study. Drug Deliv Transl Res. 2021 doi: 10.1007/s13346-021-01021-5. 

Dr Alison Halliday

After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

  • Sales Enquiry
  • Consigue una cotización
  • Technical Support
  • Encuentre un socio aprobado

Sales Enquiry

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

I'd like to receive updates from ELGA LabWater & ELGA Approved Partners based on my details.

Consigue una cotización

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

I'd like to receive updates from ELGA LabWater & ELGA Approved Partners based on my details.

Technical Support

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

Sede central de ELGA LabWater

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
Reino Unido
Tel.: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Casos prácticos

  • Abbott Diagnostics
  • Diagnóstico médico de DASA
  • Instituto Médico NeoDIN
  • Fundación del NHS de North Staffordshire
  • Escuela técnica de Olsberg

Recursos

  • Obtenga más información sobre el agua ultrapura
  • Manuales e informes técnicos
  • Tecnologías de purificación
  • Aplicaciones
  • Impurezas en el agua
  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?

© VWS (UK) Ltd. comercializado como ELGA LabWater.2025-Todos los derechos reservados.
ELGA es la marca mundial de agua de laboratorio de Veolia.

  • Política de privacidad
  • Términos y condiciones
  • Cumplimiento legal internacional
  • Patentes
  • Trademarks
  • Aviso legal
  • Idioma
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Otros sitios de Veolia
    • Veolia
    • Veolia Foundation
    • Veolia Water Technologies
Elga Veolia
TOP

© 2017 ELGA Veolia